Epilepsies associated with hypothalamic hamartomas (HHs) are frequently drug resistant with severe psychiatric and cognitive comorbidities. We performed a prospective trial to evaluate the safety and efficacy of Gamma Knife radiosurgery (GKS). Between October 1999 and October 2007, a total of 57 patients were investigated, included and treated by GKS in Timone University Hospital. Preoperative workup and 3-year postoperative evaluation consisted of seizure diary, neuropsychological, psychiatric, endocrinologic, visual field, and visual acuity examinations. Follow-up of >3 years was available for 48 patients. Topologic type was type I in 11 patients, type II in 15, type III in 17, type IV in one, type V in one, type VI in one, and mixed type in 2. The median marginal dose was 17 Gy (min 14 and max 25 Gy). The median target volume was 398 mm 3 (28-1,600 mm 3 ). Due to partial results, 28 patients (58.3%) required a second treatment. The median follow-up was 71 months (36-153 months). At last follow-up, the rate of Engel class I outcome was 39.6%, Engel class II was 29.2% (I+II 68.8%), and Engel class III was 20%. Global psychiatric comorbidity was considered cured in 28%, improved in 56%, stable in 8%, and continued to worsen in 8%. No permanent neurologic side effect was reported (in particular, no memory deficit). Nondisabling transient poikilothermia was observed in three patients (6.2%). A transient increase of seizure frequency was reported in 8 patients (16.6%) with a median duration of 30 days (9-90 days). Microsurgery was proposed because of insufficient efficacy of GKS in seven patients (14.5%) with a postoperative Engel class I-II in 28.6%. This prospective trial demonstrates very good long-term safety and efficacy of GKS for 2 patients. Beyond seizure reduction, the improvement of psychiatric and cognitive comorbidities along with better school performance and social functioning, being better socially integrated, having friends having a social life, working, participating to group activities turn out to be major benefits of GKS in this group of patients with frequently catastrophic epilepsy.
They are frequently associated with epilepsy when sessile 3 and closely connected to the mammillary bodies. [4] [5] [6] When they are in contact with the tuber cinereum and/or the infundibulum they may be associated with precocious puberty. 7 Patients with epilepsy classically start to present gelastic (laughing) seizures during the first years of life. 8 In the most severe cases, during the following years they progress to epileptic encephalopathy 9 : drug resistance, various type of seizures with generalization, drop attacks, 8 cognitive decline, [10] [11] [12] [13] and major psychiatric comorbidity. 14 Usually, seizure semiology suggests the involvement of temporal or frontal lobe structures, thus indicating probable secondary epileptogenesis. 15, 16 When epilepsy evolves toward a catastrophic symptomatic generalized epilepsy, there are frequently prominent associated cognitive impairment and behavioral disorders, sometimes with autistic features. 15, 17 Paillas first demonstrated in 1969 that epilepsy, including the signs of involvement of the temporal cortex, can be alleviated by the surgical removal of the lesion itself. 1 Direct proof of the role of HH was provided by Munari, relying on data obtained from stereo-electroencephalography (EEG) recordings. [18] [19] [20] This evidence was reinforced by ictal single-photon emission computed tomography (SPECT) studies [21] [22] [23] and other studies using depth electrodes. 11, 24, 25 Histologic studies have found c-aminobutyric acid (GABA) ergic interneuron-like phenotype with spontaneous intrinsic pacemaker-like firing and large sparse, dispersed pyramidal morphology projection neuron phenotypes. 26 Semaan et al. reported that multiple brain-derived norotrophic factor tropomyosin receptor kinase B (BDNF-TrkB) signaling pathways were activated in HH. 27 A large spectrum of surgical techniques and approaches attempting to directly tackle the HHs has been proposed. [28] [29] [30] [31] [32] We published in 2000 the first series of HH treated by Gamma Knife radiosurgery (GKS). 33 Among 10 patients, 4 were seizure-free and no side effect was reported apart from transient poikilothermia. 33 Following this first preliminary retrospective study showing a promising safety-efficacy profile of GKS, 33 we decided to launch a prospective trial.
Material and Methods
A prospective trial was organized in Marseille under the control of the health authorities and the sponsorship of Timone University Hospital. The primary end point was to assess efficacy in terms of seizure reduction. Secondary end points were the evaluation of psychiatric and neurocognitive morbidity, assessment of memory, and endocrinologic safety. After the approval of the ethic committee CCPRB1 (Comit e Consultatif de Protection des Personnes dans la Recherche Biom edicale 1), this official prospective trial was registered under the number: CM1/99/24. Between October 1999 and October 2007, a total of 57 patients were investigated, included, and treated by Gamma Knife in Timone University Hospital. Inclusion criteria were the following: patients presenting with a conspicuous HH on their MRI scan, an ongoing or past history of gelastic seizure, the demonstration of drug resistance of the underlying epilepsy, and patients being aged between 3 and 50. The parents (or patients when possible) were required to sign the informed consent. Exclusion criteria were the following: patients already included in another official trial, patients with a psychiatric disorder too severe to be amenable to radiosurgery and to allow satisfactory follow-up, patients unable to carry out EEG recording with a minimum of one video-recorded seizure, and pregnant women (Table 1) . Seven patients presenting with HH were treated by GKS during the inclusion period outside of the trial because they did not fulfill the inclusion and exclusion criteria. Preoperative workup evaluation included high-resolution magnetic resonance imaging (MRI), video-EEG recording of seizures, a seizure diary of at least the preceding 3 months before the operation, neuropsychological testing, psychiatric evaluation, endocrinologic evaluation, visual field, and visual acuity examination. The Clinical Global Impression (CGI) scoring was used as a brief psychiatric assessment tool for the measurement of illness severity (CGI-S), the global improvement or change (CGI-C), and the Efficacy Index for therapeutic response. 34 Presence of aggressive behavior (affective profile) was ascertained using the following criteria: exposing self to harm when aggressive, aggression without a purpose, unplanned aggression, being completely out of control when aggressive, unprofitable damaging of own property, and significant amount of autonomic arousal. The diagnosis of a predator profile of aggression was made based on the following criteria: less autonomic arousal, planning aggressive acts, stealing, and protecting one's own body when aggressive. 14, 35 The aggressive behavior was considered severe when it was reported to prevent the patient from attending school or have a professional occupation, to more severe, such as a patient using drugs or being in jail.
Key Points
• This is the only prospective trial evaluating a surgical technique in hypothalamic hamartomas • Gamma Knife radiosurgery in small (type I-IV) HH demonstrates an efficacy on epilepsy, psychiatric, and cognitive comorbidity comparable to that published with other surgical techniques • Severe permanent amnesic and endocrinologic complications reported with other surgical techniques (for example, transcallosal anterior interforniceal, endoscopy, and brachytherapy) are absent after GKS • Other surgical techniques and especially those still investigational will require similar prospective methodology of evaluation before reaching acceptance • Longer follow-up remains mandatory in this young population
The neuropsychological evaluation, performed in patients' native language, was depending on the age. All the patients underwent a comprehensive battery of standardized neuropsychological tests, exploring intelligence and memory (immediate and delayed verbal and visual memory). The standard clinical measures of intelligence used for IQ evaluation was the Wechsler Intelligence Scale; according to the age, the scales used were the Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI III), up to 7 years; Wechsler Intelligence Scale for Children, Fourth Edition (WISC IV), 7 to 16 years; and Wechsler Adult Intelligence Scale, Third Edition (WAIS-III), from 16 years. Memory abilities with verbal and/or visual material were assessed with the MEM III score of the Wechsler Memory Scale (WMS MEM III). Cerebral MRI was performed every 6 months during the 3 years following the intervention. All the preoperative examinations were repeated at 3 years after radiosurgery. Past history was analyzed to identify the existence of gelastic, dacrystic, complex partial seizures, secondarily generalized tonic-clonic seizures and/or status epilepticus, and to date the onset of each of this subtype of seizures. Based on patient, family, neurologist referee, and video-EEG recording, the different seizure subtypes were identified. Seizure subtypes were reanalyzed and classified according to the new terminology (gelastic, focal dyscognitive/motor, secondarily generalized tonicclonic seizure, and tonic/spasms). The analysis of the outcome in terms of seizure cessation was performed globally but also separating gelastic, complex partial seizures and secondarily generalized seizures. EEG patterns were separated into three groups: normal, focal ictal epileptic discharges (IEDs), generalized slow waves, and fast activity. The radiosurgical procedure was carried out according to previously published protocol. 5, 33, 35 
Results
In nine patients, we failed to obtain a satisfactory followup (all having been referred from distant foreign countries). Consequently, follow-up of >3 years was available for 48 patients (27 male and 21 female, with a median age of 16.5 years and range 3-50 years) of which 35 were of French nationality and 13 of other nationalities. The median follow-up was 71 months (36-153 months). Precocious puberty was reported in 23 patients (48%), and the median age of onset was 6 months. The median frequency of seizures before the intervention was 107.3 seizures/month. All the patients were presenting with gelastic seizure, 47 with focal, 16 with secondarily generalized, and 4 with tonic/ spasms. In only one patient the only subtype of seizure presented at the time of radiosurgery was gelastic seizures. In 19 patients, the neuropsychological evaluation was incomplete due either to the severity of the psychiatric comorbidity or a language barrier issue (no validated scale in the native language).
A presentation with heteroaggressive behavior was identified in 34 patients (70.8%) and was reported as severe rage behavior in 21 patients (43.8%). In 33 of these 34 patients, the aggression profile was of "affective" and in one of "predator" presentation. In 17 patients (35.4%), hyperkinetic behavior was diagnosed, and among them 10 were considered as severe. Autistic features were observed in eight patients (16.7%) and rated as severe in three patients (6.25%). Another psychiatric comorbidity was reported in 10 patients (20.8%): one obsessive compulsive disorder; one suicidal anxiety, psychotic under neuroleptic medication; one paranoia; 2 bulimia, 2 depression, and 2 patients with episodes of visual hallucinations. In 13 (27.1%) of the patients, a major attention deficit was reported. Major mental retardation (IQ <40) was established in four patients (8.3%) with no capability for reading or writing. For those of an age to attend school, sleep disturbance was reported as severe in three patients (6.25%). According to the anatomic classification described previously, 5,37 the hamartomas were of type I in 11 patients, type II in 15, type III in 17, type IV in one, type V in one, type VI in one, and mixed type in 2. The HH was associated with another brain abnormality in 19%. These abnormalities detected of the HHs were the following: T 2 -weighted increased signal of amygdala and hippocampus (one case), periventricular heterotopia associated with frontal dysgyria (one case), hippocampal dysgyric aspect associated with 18-Fluorodeoxyglucose-positron emission tomography (FDG-PET) hypometabolism (one case), prefrontal SPECT ictal hyperperfusion (one case), frontoorbital FDG-PET hypometabolism (one case), multifocal ictal SPECT hyperperfusion (two cases). A genetic disorder was clearly identified five patients: one Klinefelter syndrome, one hereditary angioedema, and Pallister-Hall syndrome in three patients (8.3%). Prior to radiosurgery, patients had undergone another neurosurgical operation in 8.3% of the cases. The demographics are presented in detail in Table 2 . Characteristics of radiosurgical procedures are summarized in supporting Table 3 . The median marginal dose was 17 Gy (min 14, max 25 Gy). The median maximum dose to the optic chiasm was 3.7 Gy (range 1.2-8.3 Gy) and the median maximum dose to the optic tract was 6.3 Gy (range 1.8-12.2 Gy). The median target volume was 398 mm 3 (28-1,600 mm 3 ). The median maximum diameter of the HH was 9 mm (range 4-30 mm). Twentyeight patients (58.3%) were treated twice due to a partial result ( Figs. 1 and 2 ).
Efficacy on seizures at last follow-up (Table 4) was complete (Engel class I), with complete seizure freedom from all types of seizure in 19 (39.6%) of the 48 patients. An additional group of 14 patients (29.2%) were almost seizure-free with rare disabling seizures (Engel class II). Therefore, a good result (Engel class I or II) was achieved in 68.8% of the patients. Eight patients (20%) had worthwhile Marginal dose is the dose prescribed at the margin of the lesion. Marginal dose 2 is the dose prescribed at the margin of the lesion for the second radiosurgical intervention.
Gy, Gray; mos, months; trt, treatment. improvement (Engel class III). Six patients (12.5%) were considered to derive no worthwhile improvement (Engel class IV) from GKS at the last follow-up (Fig. 3) . Among the patients regarded as failures at last follow-up, two experienced a seizure cessation during at least 6 months after radiosurgery followed by seizure recurrence. The median frequency of seizure was 107.3 seizures per month before radiosurgery, 16 seizures per month at 3 years, and 7 seizures per month at last follow-up. In patients experiencing seizure cessation, the median delay was 30 months with a minimum of 4 months and a maximum of 139 months. Figure 4 displays the probability of seizure cessation depending on the seizure subtype. The subtype of seizure that stopped first and was more likely to stop completely is the secondarily generalized tonic-clonic seizure and the subtype that stopped later and was less likely to stop completely is the gelastic seizure. Sequential MRI examination typically showed no contrast enhancement and no hypersignal on the T 2 or fluidattenuated inversion recovery (FLAIR) sequence at any time. Only one patient demonstrated 6 months after radiosurgery such transient changes; the patient was asymptomatic and completely seizure-free.
Efficacy on psychiatric comorbidity is reported in the subgroup of 34 patients with reported disorders (Table 5 ). In 19 (55.9%) of the 34 patients with heteroaggressive behavior before GKS, these behaviors disappeared gradually. Among the 21 with severe heteroaggressive rage, 10 were cured, 8 improved, 2 stable, and one continued to worsen. Global psychiatric comorbidity (CGI-C) was considered cured (all the features of the psychiatric comorbidity present before radiosurgery have disappeared, CGI-C: 1) in 15 patients (44.1%), much improved (CGI-C: 2) in 15 patients (44.1%), stable (CGI-C: 4) in 3 patients (8.8%), and has continued to worsen (minimally worse CGI-C: 5) in one patient (2.9%).
Impact on cognitive comorbidity
Complete neuropsychological evaluation was available in 39 patients. In these 39 patients, the neuropsychological evaluation >3 years after radiosurgery was compared with the one performed before radiosurgery. No significant decline was found, in particular, no memory deficit. We found clear improvement in 5 (among 39) of our patients. The paired analysis of change in IQ more than 3 years after radiosurgery showed a trend for improvement with a difference in the means respectively of +2. Illustrative case: Gelastic seizures since the age of 4 months, generalized seizures since the age of 12 months, and psychomotor delay but no aggressiveness or hyperactivity. Type II HH, left sided. Mean number of seizure is nine per month but frequently associated with falls and injury. GK radiosurgery (GK1) at the age of 29 with a marginal dose of 17 Gy at 50% (373 mm 3 ) . Improvement started at 5 months. At age 2 years, seizures were less frequent, smile or vague feeling without smile, and no longer has loss of consciousness and falls. Better mood and vitality according to the parents. GK2 at 4 years after GK1. Seizure cessation 1 year thereafter. Seizure-free for the last 4 years. Major improvement in quality of life with more activities, riding a horse, got driving license, work, and much better socially integrated, having friends having a social life, working, participating to group activities. From left to right axial (A, D), sagittal (B, E), and coronal (C, F) views. Above, T 2 -weighted images (A, B, C) and below 3DT1 with gadolinium images with the display of the reference marginal isodose of the radiosurgical planning (D, E, F). Both sequences were performed on a Siemens MR 1.5 Tesla. The red crosses show the correspondence between the images. In the axial view, the two red lines show the location of the sagittal and coronal images. On the sagittal view these lines show the location of the axial and coronal images, and on the coronal view, these lines show the location of the axial and sagittal images. Epilepsia ILAE (6.2%). Transient increase of seizure frequency was reported by eight patients (16.6%) with a median duration of 30 days (9-90 days). The median of the actual increase of seizure frequency based on patient diary and comparatively to the seizure frequency in the 3 months before GKS was 23.5% (min 0; max 150%). No visual deficit, no major endocrinologic side effects, and especially no morbid obesity, no diabetes insipidus, no cognitive impairment (and again no memory deficit), no motor deficit, and no mortality was reported. In one patient, a thyroid stimulating hormone (TSH) deficit was diagnosed at 2 years, which persisted at last follow-up at 5 years after the first radiosurgery. Thyroid hormone replacement allowed rapid attainment of euthyroidism with minimal overall impact on daily life. 38 Patient and family level of satisfaction (N = 44) was reported as very satisfactory in 45.5%, satisfactory in 31.8%, and not satisfactory in 22.7% of the cases.
A neurosurgical procedure due to failure or insufficient result was proposed in eight patients (14.5%). Only two of these eight patients were Engel class I or II after operation. In five of these patients (62.5%) at the last follow-up, the result of surgery was poor (Engel class III or IV) and in one case, the operation is too recent for a reliable evaluation. In a patient with a mixed form (type III + IV), the cisternal component was disconnected through a pterional approach in our center. The procedure consisted of an endoscopic surgery in six other cases (in a different center). Three of these six underwent endoscopic surgery twice (Fig. 1) . One of these three had clear cognitive and memory deterioration after the second endoscopic procedure. One of these six patients due to failure of the endoscopy was reinvestigated and underwent temporal lobectomy with a major benefit (IIB). A last patient received a vagus nerve stimulator with no benefit.
Discussion
This is the first prospective trial evaluating a surgical technique for epilepsy related to hypothalamic hamartomas. Previous series reported in the literature were until now all monocentric retrospective historical cohorts, 30 ,33,37-55 apart from one retrospective multicentric study published by Palmini et al. 28 In this group of patients presenting frequently with symptoms suggesting temporal or frontal lobe involvement, the series from Cascino et al. reported systematic failure to control seizures after temporal or frontal lobectomy. 56 Nonspecific palliative techniques such as vagus nerve stimulation 47 and callosotomies 57 were proposed with limited benefits.
The starting point of the epilepsy is nowadays recognized to be the hamartoma itself in most patients. 9, 18, 23, 58 Resection through pterional, transcallosal interforniceal (TAIF), endoscopic approaches are reported to alleviate epilepsy in 43-68% of the patients (Engel class I-II). The important surgical risks of resective surgery 28 have been dramatically reduced by skillful neurosurgeons using either endoscopic 48 or TAIF 59 approaches, with a significant reduction in the rate of major morbidity and mortality (see Table 6 ). However, endocrinologic major toxicity (malignant obesity, diabetes insipidus, etc.) is reported with these techniques. 29, 60 More recently, significant neuropsychological deterioration has also been reported in 8-75% of the patients mainly after TAIF, 52 ,61 but also after endoscopy. 29, 48, 62 With a view to reducing invasive procedures, stereotactic techniques were introduced and consist of radiofrequency thermocoagulation, brachytherapy, and radiosurgery. However, brachytherapy was also reported to be at risk for major endocrinologic complications 63 and memory worsening. 64, 65 Schulze-Bonhage reported the largest series of brachytherapy (retrospective series of 38 patients: mean age 23, range 3-54 years). According to the authors, the efficacy of brachytherapy appears lower than published data on resection and disconnection. They reported radiotoxic edema in 16% of the patients with transient impairment (headache, fatigue). Three patients needed to be treated with corticosteroids for several months; two patients had asymptomatic low sodium 3 months after interstitial radiosurgery (132 mmol/L). Permanent weight gain >5 kg (up to 24 kg) was observed in 10% of the patients, and 2 of 38 patients required oral replacement of testosterone or TSH. Deterioration of long-term memory was reported in 10-20% of the patients (Schulze-Bonhage A, communication). In 26 patients with follow-up at 1 year, Wagner from the same group showed that deteriorations occurred more frequently in declarative memory functions in 20-50% of the patients. 64 At 1 year, they found a significant decrease in verbal memory, verbal learning, visual memory, visual and verbal short-term memory, and verbal delayed recall in 50%, 42.3%, 34.6%, 23.1%, 19.2%, and 23.1%, respectively. 64 Thus interstitial brachytherapy may cause less memory deficits and avoids risks for motor deficits associated with TAI and endoscopy, but still carries cognitive decline risk, and especially memory impairment risk.
To date, no series have specifically evaluated the risk of endocrinologic and neuropsychological worsening after radiofrequency thermocoagulation. The first retrospective series of GK radiosurgery reported very good safety without major endocrinological and or neuropsychological deterioration. 5, 33, 35, 45, 66 Our prospective trial demonstrates the absence of major (one patient with a thyrotrophic deficit) endocrinologic complication with no appetite stimulation or pathologic weight gain (Castinetti et al. 2015 Epilepsia). The neuropsychological evaluation performed at 3 years after radiosurgery is showing the absence of cognitive complication and particularly the absence of memory decline described with the other techniques. GKS proves to represent the least invasive and the least risky procedure for patients with small grade I to IV HHs. There is no question that theoretically a prospective controlled randomized comparative trial with each of the resective techniques and stereotactic techniques would be mandatory to fully establish this advantage of radiosurgery. However, due to the rarity of this disease, the organization of such a prospective study would meet with considerable difficulties. The evaluation of the other surgical techniques with the strict prospective methodology that we used would considerably help us to clarify the role of each technique. It is important to evaluate following this high standard the new techniques that are still investigational such as laser thermocoagulation (LITE). 67, 68 However, an injury to the bilateral medial mammillary bodies (with MRI evidence) associated with severe permanent amnesic complication has been already reported 68 with this technique. Not all HHs are amenable to radiosurgery. It is well known that size of the target constitutes the main limitation of radiosurgery. For biophysical reasons, when the volume of the lesion increases, the very good safety/efficacy ratio of radiosurgery tends to deteriorate. Thus the large hamartomas and specially the stage VI hamartomas are not good candidates for radiosurgery. One stage V and one stage VI were treated in this trial, and in both cases, patients completely failed to respond. The best candidates for radiosurgery are small stage I, II, and III hamartomas. Large lesions, and especially large stage IV and VI lesions, are good candidates for a combined approach with, as a first step, the resection of the part of the lesion lower than the floor of the III ventricle; and in a second step, radiosurgery of the residue in the third ventricle, the hypothalamus, and the floor of the III ventricle. In our material, the EEG patterns observed before radiosurgery were not predictive of the outcome. Table 7 reports the relative frequency of each of these three patterns in the group of the seizure-free patients and the group of the non-seizure-free patients.
A second limit of radiosurgery is its delayed efficacy. In patient with very severe epilepsy deteriorating actively over time, the delayed efficacy of GKS may be problematic. , coronal (C), and 3D reconstruction. The optic pathways are drawn in orange. The yellow line corresponds to the 50% isodose line at which the marginal dose (15 Gy) was prescribed. The red crosses show the correspondence between the images. In the axial view, the two red lines show the location of the sagittal and coronal images. On the sagittal view, these lines show the location of the axial and coronal images, and on the coronal these lines show the location of the axial and sagittal images. Epilepsia ILAE Figure 4 . Kaplan-Meier curves describing the probability of seizure cessation according to time since radiosurgery depending on the seizure subtype. Epilepsia ILAE The series comes from a small number of expert centers. Among the papers from each of these centers, only the last paper with the longer follow-up and largest series was selected. When specific valuable information was available only in a former paper from the same team, this paper was also retained for the table.
Pt refers to the number of patients and "i" to the number of interventions. The mean or median volume of the lesions is reported in cubic centimeters (cc). NA means data not available. Seizure freedom is reported as the sum of class I and II of Engel classification.
Under these circumstances, resection or treatment options with more immediate efficacy might be a better option. Management of the patients who fail to respond to radiosurgery remains a difficult issue. The literature shows that all the surgical techniques reach about the same probability of seizure freedom:~60%. Thus, whatever the surgical technique, 40% of the patients get a disappointing result. After resection, finding a remnant on the postoperative MRI is a good argument for proposing a new surgical approach. Among our 48 patients, 4 failed to respond to a previous resection and 3 of 4 achieved a good outcome after radiosurgery (Engel class IA, one; class IIA, 2; class IVB, one). It is of importance before considering a new surgery to analyze the data of the preoperative workup in search of arguments in favor of the involvement of distant neural structures. In our prospective cohort, 19% of the patients presented an associated brain abnormality on preoperative MRI, SPECT, or PET. However, SPECT and PET abnormalities may represent activation of cortical regions in association with the ictal event, rather than suggesting an underlying structural defect or malformation. One of our The two groups "seizure-free" (Engel class I) and "Non-seizure-free" are compared according to distribution of patient characteristics, HH characteristics, electroclinical presentation, psychiatric and cognitive comorbidity, radiosurgical technique features. None of these features, apart from the left side of the hamartoma attachment, is significantly related to seizure freedom. For continuous variables, the median, minimum, maximum and the IQR (interquartile range) are displayed.
patients whose condition was moderately improved after radiosurgery turned out to have an involvement of mesial temporal lobe structures and subsequently became almost seizure-free after an anterior temporal lobectomy. 69 This prospective trial is the only one to date evaluating a surgical technique for epilepsy in hypothalamic hamartomas. The safety of radiosurgery is demonstrated in this study, and compares favorably with the other surgical techniques. The efficacy is similar to that reported with other surgical methods. Given this favorable safety/ efficacy profile and the absence of memory decline, it appears appropriate to consider radiosurgery as first intention treatment for epilepsy associated with small hypothalamic hamartomas.
